Oct. 26, 2025 — GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, ...
Our faculty, staff, and students make headlines every day, both on and off campus. If you have a tip for coverage of SCU in the news that we may have missed, please contact the Media Relations team.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback